Advertisement

Nutrition for Pancreatic Sufficient Individuals with Cystic Fibrosis

  • John F. PohlEmail author
  • Catherine M. McDonald
Part of the Nutrition and Health book series (NH)

Abstract

Cystic fibrosis (CF) is typically associated with exocrine pancreatic insufficiency (PI) and nutritional care of the CF patient with exocrine pancreatic sufficiency (PS) is less well described. Although patients with CF and PS typically have milder CF transmembrane conductance regulator (CFTR) gene mutations, they are still at risk of malnutrition without careful monitoring. Tests for pancreatic exocrine status should be used to determine exocrine status as well as to monitor for progression to a PI status. Such tests include the fecal elastase-1 (FE-1) immunosorbent assay which is associated with excellent sensitivity and specificity. Clinicians also should be aware that CF patients with PS are at risk of pancreatitis and testing for this scenario should be considered if clinically warranted.

Keywords

Pancreas Sufficiency Elastase Celiac Pancreatitis 

References

  1. 1.
    Cystic Fibrosis Foundation Patient Registry. 2012 annual data report. Bethesda, MD: Cystic Fibrosis Foundation; 2013.Google Scholar
  2. 2.
    Borowitz D, Baker SS, Duffy L, Baker RD, Fitzpatrick L, Gyamfi J, et al. Use of fecal elastase-1 to identify misclassification of pancreatic functional status in patients with cystic fibrosis. J Pediatr. 2004;145:322–6.CrossRefPubMedGoogle Scholar
  3. 3.
    Couper RTL, Corey M, Moore DJ, Fisher LG, Forstner GG, Drurie PR. Decline of exocrine pancreatic function in patients with pancreatic sufficiency. Pediatr Res. 1992;32:179–82.CrossRefPubMedGoogle Scholar
  4. 4.
    Bradley GM, Blackburn SM, Watson CP, Doshi VK, Cutting GR. Genetic modifiers of nutritional status in cystic fibrosis. Am J Clin Nutr. 2012;96:1299–308.PubMedCentralCrossRefPubMedGoogle Scholar
  5. 5.
    McKone EF, Goss CH, Aitken ML. CFTR genotype as a predictor of prognosis in cystic fibrosis. Chest. 2006;130:1441–7.CrossRefPubMedGoogle Scholar
  6. 6.
    Stephenson AL, Mannik LA, Walsh S, Brotherwood M, Robert R, Darling PB, et al. Longitudinal trends in nutritional status and the relation between lung function and BMI in cystic fibrosis: a population-based cohort study. Am J Clin Nutr. 2013;97:872–7.CrossRefPubMedGoogle Scholar
  7. 7.
    Dray X, Kanaan R, Bienvenu T, Desmazes-Dufeu N, Dusser D, Marteau P, et al. Malnutrition in adults with cystic fibrosis. Eur J Clin Nutr. 2005;59:152–4.CrossRefPubMedGoogle Scholar
  8. 8.
    Borowitz D, Robinson KA, Rosenfeld M, Davis SD, Sabadosa KA, Spear SL, et al. Cystic fibrosis foundation evidence-based guidelines for management of infants with cystic fibrosis. J Pediatr. 2009;155:S73–93.CrossRefPubMedGoogle Scholar
  9. 9.
    Borowitz D, Baker RD, Stallings V. Consensus on nutrition for pediatric patients with cystic fibrosis. J Pediatr Gastroenterol Nutr. 2002;35:246–59.CrossRefPubMedGoogle Scholar
  10. 10.
    Smyth AR, Bell SC, Bojcin S, Bryon M, Duff A, Flume P, et al. European cystic fibrosis society standards of care: best practice guidelines. J Cyst Fibros. 2014;13:S23–42.CrossRefPubMedGoogle Scholar
  11. 11.
    Stallings VA, Stark LJ, Robinson KA, Feranchak AP, Quinton H, Clinical Practice Guidelines on Growth and Nutrition Subcommittee, Ad Hoc Working Group. Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review. J Am Diet Assoc. 2008;108:832–9.CrossRefPubMedGoogle Scholar
  12. 12.
    Yankaskas JR, Marshall BC, Sufian B, Simon R, Rodman D. Cystic fibrosis adult care consensus conference report. Chest. 2004;125:1S–39.CrossRefPubMedGoogle Scholar
  13. 13.
    Centers for Disease Control Growth Charts. Available at http://www.cdc.gov/growthcharts/. Last Accessed 24 Nov 2014.
  14. 14.
    Martin B, Schechter M, Jaffe A, Cooper P, Bell S, Rangananthan S. Comparison of the US and Australian cystic fibrosis registries: the impact of newborn screening. Pediatrics. 2012;129(2):e348–55.CrossRefPubMedGoogle Scholar
  15. 15.
    Peterson M, Jacobs D, Milla C. Longitudinal changes in growth parameters are correlated with changes in pulmonary function in children with cystic fibrosis. Pediatrics. 2003;112(3 Pt 1):588–92.CrossRefPubMedGoogle Scholar
  16. 16.
    Grimshaw KEC, Maskell J, Oliver EM, Morris ECG, Foote KD, Mills C, et al. Introduction of complementary foods and the relationship to food allergy. Pediatrics. 2013;132:e1529–38.CrossRefPubMedGoogle Scholar
  17. 17.
    Karlberg J, Kjellmer I, Kristiansson B. Linear growth in children with cystic fibrosis. I. birth to 8 years of age. Acta Paediatr Scand. 1991;80(5):508–14.CrossRefPubMedGoogle Scholar
  18. 18.
    Ishimo M-C, Belson L, Ziai S, Levy E, Berthiaume Y, Coderre L, Rabasa-Llhoret R. Hypertriglyceridemia is associated with insulin levels in adult cystic fibrosis patients. J Cyst Fibros. 2013;12:271–6.CrossRefPubMedGoogle Scholar
  19. 19.
    US preventive services task force. Final recommendation statement lipid disorders in adults (cholesterol, dyslipidemia): screening. Available at http://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/lipid-disorders-in-adults-cholesterol-dyslipidemia-screening.Last Accessed 19 Nov 2014.
  20. 20.
    Rana M, Wong-See D, Katz T, Gaskin K, Whitehead B, Jaffe A, et al. Fat-soluble vitamin deficiency in children and adolescents with cystic fibrosis. J Clin Pathol. 2014;67:605–8.CrossRefPubMedGoogle Scholar
  21. 21.
    Brei C, Simon A, Krawinkel M, Naehrlich L. Individualized vitamin A supplementation for patients with cystic fibrosis. Clin Nutr. 2013;32(5):805–10.CrossRefPubMedGoogle Scholar
  22. 22.
    Roddy M, Greally P, Clancy G, Leen G, Feehan S, Elnazir B. Night blindness in a teenager with cystic fibrosis. Nutr Clin Pract. 2011;26(6):718–21.CrossRefPubMedGoogle Scholar
  23. 23.
    Sheikh S, Gemma S, Patel A. Factors associated with low bone mineral density in patients with cystic fibrosis. J Bone Miner Metab. 2014;33(2):180–5.CrossRefPubMedGoogle Scholar
  24. 24.
    Javier R, Jacquot J. Bone disease in cystic fibrosis: what’s new? Joint Bone Spine. 2011;78(5):445–50.CrossRefPubMedGoogle Scholar
  25. 25.
    Gilbert C, Arum S, Smith C. Vitamin D deficiency and chronic lung disease. Can Respir J. 2009;16(3):75–80.PubMedCentralPubMedGoogle Scholar
  26. 26.
    Rosecrans R, Dohnal J. Seasonal vitamin D changes and the impact on health risk assessment. Clin Biochem. 2014;47(7–8):670–2.CrossRefPubMedGoogle Scholar
  27. 27.
    Chakrabarty B, Kabra S, Gulati S, Toteja G, Lodha R, Kabra M, et al. Peripheral neuropathy in cystic fibrosis: a prevalence study. J Cyst Fibros. 2013;12(6):754–60.CrossRefPubMedGoogle Scholar
  28. 28.
    Bertolaso C, Groleau V, Schall J, Maqbool A, Mascarenhas M, Latham N, et al. Fat-soluble vitamins in cystic fibrosis and pancreatic insufficiency: efficacy of nutrition intervention. J Pediatr Gastroenterol Nutr. 2014;58(4):443–8.PubMedCentralCrossRefPubMedGoogle Scholar
  29. 29.
    Yadav K, Singh M, Angurana S, Attri S, Sharma G, Tageja M, et al. Evaluation of micronutrient profile in North Indian children with cystic fibrosis: a case–control study. Pediatr Res. 2014;75(6):762–6.CrossRefPubMedGoogle Scholar
  30. 30.
    Uijterschout L, Nuijsink M, Hendriks D, Vos R, Brus F. Iron deficiency occurs frequently in children with cystic fibrosis. Pediatr Pulmonol. 2014;49(5):458–62.CrossRefPubMedGoogle Scholar
  31. 31.
    Marviq R, Damkiaer S, Khademi S, Markussen T, Molin S, Jelsbak L. Within-host evolution of pseudomonas aeruginosa reveals adaption toward iron acquisition from hemoglobin. MBio. 2014;5(3):e00966–14.Google Scholar
  32. 32.
    Coates A, Crofton P, Marshall T. Evaluation of salt supplementation in CF infants. J Cyst Fibros. 2009;8(6):382–5.CrossRefPubMedGoogle Scholar
  33. 33.
    Ferguson J, Chang A. Vitamin D supplementation for cystic fibrosis. Cochrane Database Syst Rev. 2014;5:CD007298.PubMedGoogle Scholar
  34. 34.
    Gontijo-Amaral C, Guimaraes E, Camargos P. Oral magnesium supplementation in children with cystic fibrosis improves clinical and functional variables: a double-blind, randomized, placebo-controlled crossover trial. Am J Clin Nutr. 2012;96(1):50–6.CrossRefPubMedGoogle Scholar
  35. 35.
    Kotilea K, Quennery S, Decroes V, Hermans D. Successful sublingual cobalamin treatment in a child with short bowel syndrome. J Pediatr Pharmacol Ther. 2014;19(1):60–3.PubMedCentralPubMedGoogle Scholar
  36. 36.
    Maqbool A, Schall J, Mascarenhas M, Dougherty K, Stallings V. Vitamin B12 status in children with cystic fibrosis and pancreatic insufficiency. J Pediatr Gastroenterol Nutr. 2014;58(6):733–8.PubMedCentralPubMedGoogle Scholar
  37. 37.
    Weintraub A, Blau H, Mussaffi H, Picard E, Bentur L, Kerem E, et al. Exocrine pancreatic function testing in patients with cystic fibrosis and pancreatic sufficiency: a correlation study. J Pediatr Gastroenterol Nutr. 2009;48(3):306–10.CrossRefPubMedGoogle Scholar
  38. 38.
    Pohl J, Easley D. Pancreatic insufficiency in children. Pract Gastroenterol. 2003;27(10):38–48.Google Scholar
  39. 39.
    Luth S, Teyssen S, Forssmann K, Kolbel C, Krummenauer F, Singer M. Fecal elastase-1 determination: ‘gold standard’ of indirect pancreatic function tests? Scand J Gastroenterol. 2001;36(10):1092–6.CrossRefPubMedGoogle Scholar
  40. 40.
    Gokce M, Tuncer M, Cetin M, Gumruk F. Molecular diagnosis of Schwachman–Diamond syndrome presenting with pancytopenia at an early age: the first report from Turkey. Indian J Hematol Blood Transfus. 2013;29(3):161–3.PubMedCentralCrossRefPubMedGoogle Scholar
  41. 41.
    Carroccio A, Verghi F, Santini B, Lucidi V, Iacono G, Cavataio F, et al. Diagnostic accuracy of fecal elastase 1 assay in patients with pancreatic maldigestion or intestinal malabsorption: a collaborative study of the Italian Society of Pediatric Gastroenterology and Hepatology. Dig Dis Sci. 2001;46(6):1335–42.CrossRefPubMedGoogle Scholar
  42. 42.
    Salvatore S, Finazzi S, Barassi A, Verzelletti M, Tosi A, Melzi d’Eril G, et al. Low fecal elastase: potentially related to transient small bowel damage resulting from enteric pathogens. J Pediatr Gastroenterol Nutr. 2003;36(3):392–6.CrossRefPubMedGoogle Scholar
  43. 43.
    Evans K, Leeds J, Morley S, Sanders D. Pancreatic insufficiency in adult celiac disease: do patients require long-term enzyme supplementation? Dig Dis Sci. 2010;55(10):2999–3004.CrossRefPubMedGoogle Scholar
  44. 44.
    Walkowiak J, Herzig K. Fecal elastase-1 is decreased in villous atrophy regardless of the underlying disease. Eur J Clin Invest. 2001;31(5):425–30.CrossRefPubMedGoogle Scholar
  45. 45.
    O’Sullivan BP, Baker D, Leung KG, Reed G, Baker SS, Borowitz D. Evolution of pancreatic function during the first year in infants with cystic fibrosis. J Pediatr. 2013;162:808–12.CrossRefPubMedGoogle Scholar
  46. 46.
    Walkowiak J, Nousia-Arvanitakis S, Agguridaki C, Fotoulaki M, Strzykala K, Balassopoulou A, et al. Longitudinal follow-up of exocrine pancreatic function in pancreatic sufficient cystic fibrosis patients using fecal elastase-1 test. J Pediatr Gastroenterol Nutr. 2003;36(4):474–8.CrossRefPubMedGoogle Scholar
  47. 47.
    Doull I. What and when to collect from infants with cystic fibrosis. Arch Dis Child. 2007;92(10):831–2.PubMedCentralCrossRefPubMedGoogle Scholar
  48. 48.
  49. 49.
    Pohl J, Judkins J, Meihls S, Lowichik A, Chatfield B, McDonald C. Cystic fibrosis and celiac disease: both can occur together. Clin Pediatr. 2011;50(12):1153–5.CrossRefGoogle Scholar
  50. 50.
    Fluge G, Olesen H, Gilljam M, Meyer P, Pressler T, Storroston O, et al. Co-morbidity of cystic fibrosis and celiac disease in Scandinavian cystic fibrosis patients. J Cyst Fibros. 2009;8(3):198–202.CrossRefPubMedGoogle Scholar
  51. 51.
    Walkowiak J, Blask-Osipa A, Lisowska A, Oralewska B, Pogorzelski A, Cichy W, et al. Cystic fibrosis is a risk factor for celiac disease. Acta Biochim Pol. 2010;57(1):115–8.PubMedGoogle Scholar
  52. 52.
    Dickson B, Streutker C, Chetty R. Coeliac disease: an update for pathologists. J Clin Pathol. 2006;59(10):1008–16.PubMedCentralCrossRefPubMedGoogle Scholar
  53. 53.
    Institute AGA. AGA Institute medical position statement on the diagnosis and management of celiac disease. Gastroenterology. 2006;131(6):1977–80.CrossRefGoogle Scholar
  54. 54.
    Hill I, Dirks M, Liptak G, Colletti R, Fasano A, Guadalini S, et al. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2005;40:1–19.CrossRefPubMedGoogle Scholar
  55. 55.
    Terlizzi V, Tosco A, Tomaiuolo R, Sepe A, Amato N, Casale A, et al. Prediction of acute pancreatitis risk based on PIP score in children with cystic fibrosis. J Cyst Fibros. 2014;13(5):579–84.CrossRefPubMedGoogle Scholar
  56. 56.
    Ooi C, Durie P. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in pancreatitis. J Cyst Fibros. 2012;11(5):355–62.CrossRefPubMedGoogle Scholar
  57. 57.
    De Boeck K, Weren M, Proesmans M, Kerem E. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype. Pediatrics. 2005;115(4):e463–9.CrossRefPubMedGoogle Scholar
  58. 58.
    Masson E, Chen J, Audrezet M, Cooper D, Ferec C. A conservative assessment of the major genetic causes of idiopathic chronic pancreatitis: data from a comprehensive analysis of PRSS1, SPINK1, CTRC and CFTR genes in 253 young French patients. PLoS One. 2013;8(8):e73522.PubMedCentralCrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  1. 1.Division of Pediatric Gastroenterology, Department of Pediatrics, Primary Children’s HospitalUniversity of UtahSalt Lake CityUSA

Personalised recommendations